Sanofi becomes latest drugmaker to announce insulin price cuts, capping cost at $35 for the privately insured
By Tami Luhby, CNN Sanofi is cutting the list price of Lantus, its most widely prescribed insulin in the US, by 78% and establishing a $35 monthly cap for those with private insurance, the company announced Thursday. The change is effective January 1. The move follows similar ones by Eli Lilly and Novo Nordisk this
Continue Reading